Activest Wealth Management Bio N Tech Se Transaction History

Activest Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$98.5 - $125.08 $0 - $0	0 New	0 $0
Q3 2022 Oct 13, 2022	BUY	$127.65 - $183.11 $49,783 - $71,412	390 Added 39000.0%	391 $53,000
Q1 2022 Apr 26, 2022	SELL	$126.25 - $231.85 $15,150 - $27,822	-120 Reduced 99.17%	1 $0
Q4 2021 Jan 13, 2022	BUY	$216.64 - $362.52 $26,213 - $43,864	121 New	121 $31,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Activest Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Activest Wealth Management with notifications on news.